Plain-English translation of NCT06485609 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests whether adding indocyanine green fluorescence imaging—a special technique that uses a fluorescent dye to highlight cancer-affected lymph nodes during surgery—improves outcomes for people with right colon cancer. Surgeons will use this imaging during minimally invasive (laparoscopic) colon removal surgery. The study compares standard surgery alone to surgery combined with this new imaging technique to see which approach gives patients better long-term results.
Right colon cancer surgery requires removing lymph nodes to check for cancer spread, but surgeons may miss some affected nodes using standard methods. This new imaging technique could help surgeons find and remove more cancer-affected lymph nodes, potentially improving survival rates and reducing the chance of cancer returning.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, you will be randomly assigned to receive either standard colon cancer removal surgery or the same surgery combined with indocyanine green fluorescence imaging to help identify cancer-affected lymph nodes. The surgery itself will be performed laparoscopically (using small incisions and a camera). After surgery, you will have follow-up visits to monitor your recovery and long-term outcomes, with the study tracking your health over time to compare how well each approach works.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China